Evaluation of Biocoat® Intestinal Epithelium Differentiation Environment (3-Day Cultured Caco-2 Cells) as an Absorption Screening Model with Improved Productivity

[1]  Malcolm Rowland,et al.  Comparison of HT29-18-C1 and Caco-2 Cell Lines as Models for Studying Intestinal Paracellular Drug Absorption , 1996, Pharmaceutical Research.

[2]  T. Bjornsson,et al.  Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans , 1995, Clinical pharmacology and therapeutics.

[3]  P. Artursson,et al.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.

[4]  W. Martin,et al.  Pharmacokinetics and absolute bioavailability of ibuprofen after oral administration of ibuprofen lysine in man. , 1990, Biopharmaceutics & drug disposition.

[5]  S. Singhvi,et al.  Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects. , 1990, British journal of clinical pharmacology.

[6]  R. H. Meacham,et al.  Disposition of 14C‐guanabenz in patients with essential hypertension * , 1980, Clinical pharmacology and therapeutics.

[7]  S. Chong,et al.  In Vitro Permeability Through Caco-2 Cells is not Quantitatively Predictive of in Vivo Absorption for Peptide-Like Drugs Absorbed via the Dipeptide Transporter System , 2004, Pharmaceutical Research.

[8]  J. Paulson,et al.  Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate. , 1989, British journal of clinical pharmacology.

[9]  W. Ritschel.  Handbook of basic pharmacokinetics , 1976 .